SAE1 Stock Overview
Operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Redcare Pharmacy NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €10.20 |
| 52 Week High | €16.00 |
| 52 Week Low | €8.30 |
| Beta | 1.07 |
| 1 Month Change | -13.56% |
| 3 Month Change | -27.14% |
| 1 Year Change | 10.27% |
| 3 Year Change | -29.17% |
| 5 Year Change | n/a |
| Change since IPO | -24.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| SAE1 | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | -18.4% | -3.2% | -0.3% |
| 1Y | 10.3% | -38.9% | 4.5% |
Return vs Industry: SAE1 exceeded the German Consumer Retailing industry which returned -39.1% over the past year.
Return vs Market: SAE1 exceeded the German Market which returned 4.3% over the past year.
Price Volatility
| SAE1 volatility | |
|---|---|
| SAE1 Average Weekly Movement | 9.7% |
| Consumer Retailing Industry Average Movement | 6.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: SAE1's share price has been volatile over the past 3 months.
Volatility Over Time: SAE1's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,900 | Olaf Heinrich | www.redcare-pharmacy.com |
Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023.
Redcare Pharmacy NV Fundamentals Summary
| SAE1 fundamental statistics | |
|---|---|
| Market cap | €2.24b |
| Earnings (TTM) | -€9.62m |
| Revenue (TTM) | €1.99b |
1.1x
P/S Ratio-232.7x
P/E RatioIs SAE1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAE1 income statement (TTM) | |
|---|---|
| Revenue | €1.99b |
| Cost of Revenue | €1.52b |
| Gross Profit | €468.17m |
| Other Expenses | €477.80m |
| Earnings | -€9.62m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 30, 2024
| Earnings per share (EPS) | -0.47 |
| Gross Margin | 23.56% |
| Net Profit Margin | -0.48% |
| Debt/Equity Ratio | 44.8% |
How did SAE1 perform over the long term?
See historical performance and comparison